The significance of these arrays reiterates the number of downstream effects that HEY1 can have as a transcriptional repressor on downstream genes that might all contribute to the development of GBM traits related to its aggressive and treatment-resistant nature. The gene discussed is HEY1; the disease is glioblastoma.